1. MicroRNAs in the pathogenesis of type 2 diabetes: new research progress and future direction.
   Chenggui Miao et al, 2017, Can. J. Physiol. Pharmacol. CrossRef
2. MicroRNAs as stress regulators in pancreatic beta cells and diabetes
   Mary P. LaPierre et al, 2017, Molecular Metabolism CrossRef
3. Molecular mechanism for miR-350 in regulating of titanium dioxide nanoparticles in macrophage RAW264.7 cells
   Jing Sui et al, 2017, Chemico-Biological Interactions CrossRef
4. The Destiny of Glucose from a MicroRNA Perspective
   Paola Mirra et al, 2018, Front. Endocrinol. CrossRef
5. MiRNA-92a protects pancreatic B-cell function by targeting KLF2 in diabetes mellitus
   Wenyi Wang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
6. MicroRNAs in type 2 diabetes mellitus: Important for the pathogenesis but uncertain as biomarkers
   Jingwei Yu et al, 2018, Journal of Diabetes CrossRef
7. Epigenetics Variation and Pathogenesis in Diabetes.
   Haichen Zhang et al, 2018, Curr Diab Rep CrossRef
8. SOCS3 as a future target to treat metabolic disorders
   João A.B. Pedroso et al, 2018, Hormones CrossRef
9. MicroRNA-19a-3p promotes rheumatoid arthritis fibroblast-like synoviocytes via targeting SOCS3
   Yiyue Chen et al, 2019, J Cell Biochem CrossRef
10. Pancreatic β-cell function is inhibited by miR-3666 in type 2 diabetes mellitus by targeting adiponectin
    J. Tan et al, 2019, Braz J Med Biol Res CrossRef
11. Intragenic regulation of SOCS3 isoforms
    Oliver Klepsch et al, 2019, Cell Commun Signal CrossRef
12. MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment
    Shan Wan et al, 2020, Front. Endocrinol. CrossRef
13. MiR-330-3p contributes to INS-1 cell dysfunction by targeting glucokinase in gestational diabetes mellitus
    Yuping Xiao et al, 2020, J. Obstet. Gynaecol. Res. CrossRef
14. A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1
    Kim B. Luley et al, 2020, Cancers CrossRef
15. MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice
    Shu Fang et al, 2020, Adipocyte CrossRef
16. Inhibition of miR-19a-3p decreases cerebral ischemia/reperfusion injury by targeting IGFBP3 in vivo and in vitro.
    Zhaohui Chai et al, 2020, Biol Res CrossRef
17. A microRNA‑24‑to‑secretagogin regulatory pathway mediates cholesterol‑induced inhibition of insulin secretion
    Jing Yang et al, 2019, Int J Mol Med CrossRef
18. miR‑19a promotes vascular smooth muscle cell proliferation, migration and invasion through regulation of Ras homolog family member B
    Gengxin Sun et al, 2019, Int J Mol Med CrossRef
19. Silencing of miR‑19a‑3p enhances osteosarcoma cells chemosensitivity by elevating the expression of tumor suppressor PTEN
    Bo Zhang et al, 2018, Oncol Lett CrossRef
20. null
    Claudiane Guay et al, 2020 CrossRef
21. Inhibited histone deacetylase 3 ameliorates myocardial ischemia–reperfusion injury in a rat model by elevating microRNA ‐19a‐3p and reducing cyclin‐dependent kinase 2
    Kaiyou Song et al, 2020, IUBMB Life CrossRef
22. null
    Paul Holvoet, 2021 CrossRef
23. null
    Paul Holvoet, 2021 CrossRef
24. miR-124-3p Down-Regulation Influences Pancreatic-β-Cell Function by Targeting Secreted Frizzled-Related Protein 5 (SFRP5) in Diabetes Mellitus
    Zhenhuan Jiang et al, 2021, j biomater tissue eng CrossRef
25. Progression of Type 1 Diabetes: Circulating MicroRNA Expression Profiles Changes from Preclinical to Overt Disease
    Aritania Sousa Santos et al, 2022, Journal of Immunology Research CrossRef
26. miRNAs: Regulators of Immune System in Diabetes
    Helaleh Vaezi Heris et al, 2022, Mutation Research/Reviews in Mutation Research CrossRef
27. Role of lncRNA‐ MEG8 / miR ‐296‐3p axis in gestational diabetes mellitus
    Guiping Bian et al, 2022, Nephrology CrossRef
28. Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview
    PADS Palihaderu et al, 2022, Genet Epigenet CrossRef
29. Expression of microRNAs in patients with gestational diabetes mellitus: a systematic review and meta-analysis
    Jianhua Li et al, 2022, Acta Diabetol CrossRef
30. Regulatory mechanisms of microRNAs in endocrine disorders and their therapeutic potential
    S. Janin Ledesma-Pacheco et al, 2023, Front. Genet. CrossRef
31. A Review of micro RNAs changes in T2DM in animals and humans
    Mohammad Reza Afsharmanesh et al, 2023, Journal of Diabetes CrossRef